• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
HealthCommentary

What Big Tech’s New Alliance Means for the Health of AI

By
David Meyer
David Meyer
Down Arrow Button Icon
By
David Meyer
David Meyer
Down Arrow Button Icon
August 14, 2018, 6:58 AM ET

Some of the biggest tech giants yesterday agreed to build health care products that use a common set of standards in order to make it easier to share medical data across hospitals. What’s more, these are open standards and specifications aimed at encouraging “frictionless data exchange.”

The agreement between Amazon, Google, IBM, Microsoft, Oracle and Salesforce is good news for medical professionals and their patients, because having more information at hand potentially aids speedy diagnosis and treatment. If the promised efficiencies materialize, there may even be savings on the horizon.

The openness of the standards is also very good news for the future competitiveness of the health care IT market, because it should lower the barriers to entry for companies that aren’t at the scale that these giants currently enjoy.

But the deal is also clearly good for its signatories, not only because it expands their potential markets, but because it will help feed their artificial intelligence ambitions. More data, if properly wrangled, translates to smarter AI.

And the companies need smarter AI. Consider the case of IBM and its marquee Watson system, which was recently the subject of quite the takedown by the Wall Street Journal. It turns out that more than a dozen clients and partners have scaled down or ended their experiments with using Watson in cancer treatment.

Here’s the relevant bit from that piece: “In many cases, the tools didn’t add much value. In some cases, Watson wasn’t accurate. Watson can be tripped up by a lack of data in rare or recurring cancers, and treatments are evolving faster than Watson’s human trainers can update the system.”

There’s a lesson in here about taking a realistic view of where AI’s development stands today. But there’s another takeaway too: perhaps health care is too sprawling an environment for one company, no matter how venerable and well-resourced, to provide all the value that’s needed on its own. If that’s the case, then there’s much cause to celebrate an agreement that breaks down silos, opens up markets, and hopefully saves lives.

A version of this story first appeared in CEO Daily, Coins2Day’s daily newsletter on succeeding big in business. Subscribe here.

About the Author
By David Meyer
LinkedIn icon
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.